Legal & General Group’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,579
| Closed | -$2.05K | – | 3504 |
|
|
2025
Q1 | $2.05K | Hold |
6,579
| – | – | ﹤0.01% | 3352 |
|
|
2024
Q4 | $6.14K | Hold |
6,579
| – | – | ﹤0.01% | 3325 |
|
|
2024
Q3 | $7.76K | Hold |
6,579
| – | – | ﹤0.01% | 3316 |
|
|
2024
Q2 | $5.06K | Buy |
6,579
+1,378
| +26% | +$1.06K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $15.9K | Hold |
5,201
| – | – | ﹤0.01% | 3060 |
|
|
2023
Q4 | $16.7K | Buy |
5,201
+588
| +13% | +$1.89K | ﹤0.01% | 3102 |
|
|
2023
Q3 | $17.7K | Sell |
4,613
-1,150
| -20% | -$4.42K | ﹤0.01% | 3085 |
|
|
2023
Q2 | $18.9K | Buy |
+5,763
| New | +$18.9K | ﹤0.01% | 3130 |
|
|
2021
Q2 | – | Sell |
-5,199
| Closed | -$21K | – | 3605 |
|
|
2021
Q1 | $21K | Sell |
5,199
-21,322
| -80% | -$86.1K | ﹤0.01% | 3116 |
|
|
2020
Q4 | $61K | Buy |
26,521
+21,322
| +410% | +$49K | ﹤0.01% | 2746 |
|
|
2020
Q3 | $30K | Sell |
5,199
-1,863
| -26% | -$10.8K | ﹤0.01% | 2851 |
|
|
2020
Q2 | $52K | Buy |
+7,062
| New | +$52K | ﹤0.01% | 2718 |
|
|
2019
Q3 | – | Sell |
-2,145
| Closed | -$4K | – | 3398 |
|
|
2019
Q2 | $4K | Hold |
2,145
| – | – | ﹤0.01% | 3459 |
|
|
2019
Q1 | $4K | Hold |
2,145
| – | – | ﹤0.01% | 3321 |
|
|
2018
Q4 | $5K | Hold |
2,145
| – | – | ﹤0.01% | 3336 |
|
|
2018
Q3 | $12K | Hold |
2,145
| – | – | ﹤0.01% | 3302 |
|
|
2018
Q2 | $17K | Hold |
2,145
| – | – | ﹤0.01% | 3227 |
|
|
2018
Q1 | $15K | Buy |
2,145
+1,047
| +95% | +$7.32K | ﹤0.01% | 3162 |
|
|
2017
Q4 | $11K | Hold |
1,098
| – | – | ﹤0.01% | 3227 |
|
|
2017
Q3 | $10K | Hold |
1,098
| – | – | ﹤0.01% | 3278 |
|
|
2017
Q2 | $11K | Buy |
+1,098
| New | +$11K | ﹤0.01% | 3307 |
|